Bridgeway Capital Management’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Buy |
102,000
+62,414
| +158% | +$68K | ﹤0.01% | 1053 |
|
|
2025
Q1 | $38.5K | Sell |
39,586
-70,000
| -64% | -$68.1K | ﹤0.01% | 1133 |
|
|
2024
Q4 | $162K | Buy |
109,586
+21,500
| +24% | +$31.8K | ﹤0.01% | 1041 |
|
|
2024
Q3 | $187K | Sell |
88,086
-37,000
| -30% | -$78.4K | ﹤0.01% | 1082 |
|
|
2024
Q2 | $305K | Buy |
125,086
+40,000
| +47% | +$97.6K | 0.01% | 969 |
|
|
2024
Q1 | $551K | Hold |
85,086
| – | – | 0.01% | 898 |
|
|
2023
Q4 | $328K | Sell |
85,086
-10,425
| -11% | -$40.2K | 0.01% | 1051 |
|
|
2023
Q3 | $204K | Buy |
95,511
+10,000
| +12% | +$21.4K | 0.01% | 1097 |
|
|
2023
Q2 | $261K | Buy |
85,511
+3,800
| +5% | +$11.6K | 0.01% | 1073 |
|
|
2023
Q1 | $212K | Hold |
81,711
| – | – | 0.01% | 1094 |
|
|
2022
Q4 | $168K | Buy |
81,711
+40,000
| +96% | +$82K | ﹤0.01% | 1130 |
|
|
2022
Q3 | $188K | Buy |
41,711
+5,500
| +15% | +$24.8K | 0.01% | 1153 |
|
|
2022
Q2 | $148K | Buy |
+36,211
| New | +$148K | ﹤0.01% | 1153 |
|